Cargando…

Tamoxifen and Ovarian Function

BACKGROUND: Some studies suggest that the clinical parameter “amenorrhea” is insufficient to define the menopausal status of women treated with chemotherapy or tamoxifen. In this study, we investigated and compared the ovarian function defined either by clinical or biological parameters in pre-menop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berliere, Martine, Duhoux, Francois P., Dalenc, Florence, Baurain, Jean-Francois, Dellevigne, Laurence, Galant, Christine, Van Maanen, Aline, Piette, Philippe, Machiels, Jean-Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695994/ https://www.ncbi.nlm.nih.gov/pubmed/23840510 http://dx.doi.org/10.1371/journal.pone.0066616

Ejemplares similares

Correction: Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013)

Breast Development and Cancer
por: Berliere, Martine, et al.
Publicado: (2023)

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
por: Berliere, Martine, et al.
Publicado: (2008)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial
por: Forget, Patrice, et al.
Publicado: (2019)

Effects of Hormones on Breast Development and Breast Cancer Risk in Transgender Women
por: Berliere, Martine, et al.
Publicado: (2022)

Characterization of Preoperative, Postsurgical, Acute and Chronic Pain in High Risk Breast Cancer Patients
por: Forget, Patrice, et al.
Publicado: (2020)

Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families
por: Van Marcke, Cédric, et al.
Publicado: (2020)

Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
por: Derouane, Françoise, et al.
Publicado: (2022)

Impact of Perioperative Hypnosedation on Postmastectomy Chronic Pain: Preliminary Results
por: Lacroix, Camille, et al.
Publicado: (2019)

BRCA1 Mutation: An Insidious Enemy with Multiple Facets…
por: Godin, Pierrick, et al.
Publicado: (2022)

The Place of Extensive Surgery in Locoregional Recurrence and Limited Metastatic Disease of Breast Cancer: Preliminary Results
por: Berlière, M., et al.
Publicado: (2015)

Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Berliere, Martine, et al.
Publicado: (2021)

Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
por: Migeotte, A., et al.
Publicado: (2021)

Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell Cancer
por: Pasoglou, Vassiliki, et al.
Publicado: (2022)

Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer
por: Luyckx, Mathieu, et al.
Publicado: (2014)

Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways
por: Dalenc, Florence, et al.
Publicado: (2005)

Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck
por: Seront, Emmanuel, et al.
Publicado: (2019)

Interendoscopist variability in proximal colon polyp detection is twice higher for serrated polyps than adenomas
por: Bretagne, Jean-François, et al.
Publicado: (2016)

Lymphoid neogenesis in melanoma: What does it tell us?
por: van Baren, Nicolas, et al.
Publicado: (2013)

Texture analysis on MR images helps predicting non-response to NAC in breast cancer
por: Michoux, N., et al.
Publicado: (2015)

Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer
por: Franchet, Camille, et al.
Publicado: (2021)

Ovarian cysts in women receiving tamoxifen for breast cancer
por: Mourits, M J E, et al.
Publicado: (1999)

Tamoxifen-associated polypoid endometriosis mimicking an ovarian neoplasm
por: Choi, In Ho, et al.
Publicado: (2015)

A Synopsis of Serum Biomarkers in Cutaneous Melanoma Patients
por: Vereecken, Pierre, et al.
Publicado: (2012)

Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials
por: Yan, Shunchao, et al.
Publicado: (2015)

Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Morphological and Immunohistochemical Study of Ovarian and Tubal Dysplasia Associated with Tamoxifen
por: Chene, G., et al.
Publicado: (2014)

Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
por: Schmitz, Sandra, et al.
Publicado: (2015)

Advances in the management of squamous cell carcinoma of the head and neck
por: Machiels, Jean-Pascal, et al.
Publicado: (2014)

Fertility Sparing Treatment in Patients With Early Stage Endometrial Cancer, Using a Combination of Surgery and GnRH Agonist: A Monocentric Retrospective Study and Review of the Literature
por: Tock, Stéphanie, et al.
Publicado: (2018)

Combined HP (13)C Pyruvate and (13)C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma Xenografts
por: Farah, Chantale, et al.
Publicado: (2022)

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer
por: Bertucci, Alexandre, et al.
Publicado: (2020)

Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.
por: Osborne, R. J., et al.
Publicado: (1988)

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
por: Hasan, J, et al.
Publicado: (2005)

Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021)

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study
por: van Marcke, C., et al.
Publicado: (2021)

Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report
por: Collette, Fanny, et al.
Publicado: (2020)

Efficacy of tamoxifen for the treatment of severe equine asthma
por: Mainguy‐Seers, Sophie, et al.
Publicado: (2018)

Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer
por: Lee Meeuw Kjoe, Philippe R, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_calsqn7p0p5jlsf506m44b0jvv